Saregama India Limited (SAREGAMA.BO)
INR 500.05
(-0.1%)
INR 500.05
(-0.1%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.47 Billion | 934.3 Million | 944.25 Million | 1.89 Billion | 793.38 Million | -357.28 Million |
| Net Income | 1.97 Billion | 2.48 Billion | 2.04 Billion | 1.51 Billion | 603.47 Million | 846.79 Million |
| Depreciation & Amortization | 361.8 Million | 208.19 Million | 131.01 Million | 56.1 Million | 46.37 Million | 33.25 Million |
| Deferred income taxes | - | -818.29 Million | -707.64 Million | -189.56 Million | -243.42 Million | -186.04 Million |
| Stock-based compensation | 96.6 Million | 30.7 Million | 7.57 Million | 13.77 Million | 2.17 Million | 305 Thousand |
| Change in working capital | -861.6 Million | -446.8 Million | -389.06 Million | 691.24 Million | 388.33 Million | -915.71 Million |
| Other non-cash items | 1.25 Billion | -520.24 Million | -141.74 Million | -193.48 Million | -3.54 Million | -135.87 Million |
| Investing Cash Flow | -402.1 Million | -1.48 Billion | -6.3 Billion | -1.36 Billion | -50.22 Million | -63.49 Million |
| Investments in PPE | -922.7 Million | -1.03 Billion | -727.13 Million | -220.07 Million | -82.78 Million | -121.04 Million |
| Acquisitions | -1.66 Billion | - | - | -9.3 Million | 12 Thousand | 80 Thousand |
| Investment purchases | -2.25 Billion | -7.61 Billion | -6.84 Billion | -1.22 Billion | -16.2 Million | -20 Million |
| Sales/Maturities of investments | 4.43 Billion | 7.02 Billion | 1.13 Billion | - | 15.01 Million | 20.04 Million |
| Other Investing Activities | 2.75 Billion | 139.02 Million | 137.32 Million | 97.94 Million | 33.74 Million | 57.43 Million |
| Financing Cash Flow | -818.6 Million | -752.36 Million | 6.77 Billion | -494.8 Million | -724.66 Million | 378.57 Million |
| Debt repayment | -14 Million | -5.9 Million | -4.18 Million | -92.32 Million | -545.33 Million | -478.92 Million |
| Dividends payments | -771.23 Million | -578.42 Million | -578.42 Million | -374.69 Million | -63 Million | -51.53 Million |
| Common Stock Repurchased | -21.9 Million | -160.77 Million | - | -17.11 Million | -76.43 Million | - |
| Common Stock Issuance | - | - | 7.36 Billion | 487 Thousand | 2.12 Million | - |
| Other Financing Activities | -44.3 Million | -13.16 Million | -14.76 Million | -11.14 Million | -52.76 Million | 909.03 Million |
| Accounts receivables | 40.4 Million | -500.27 Million | -200.24 Million | 203.22 Million | 6.36 Million | -323.89 Million |
| Accounts payables | 50.2 Million | 51.97 Million | 82.19 Million | 22.14 Million | 23.39 Million | 173.96 Million |
| Inventory | -626.1 Million | -632.55 Million | -362.45 Million | 244.42 Million | 26.6 Million | -469.83 Million |
| Other working capital | -326.1 Million | 634.04 Million | 91.43 Million | 221.44 Million | 331.97 Million | -295.95 Million |
| Cash at beginning of period | 172.63 Million | 1.52 Billion | 111.34 Million | 70.47 Million | 50.02 Million | 92.17 Million |
| Cash at end of period | 5.42 Billion | 167.03 Million | 1.52 Billion | 111.34 Million | 70.47 Million | 50.02 Million |
| Capital Expenditure | -922.7 Million | -1.03 Billion | -727.13 Million | -220.07 Million | -82.78 Million | -121.04 Million |
| Effect of forex changes on cash | 3.7 Million | 16.24 Million | 2.43 Million | -405 Thousand | 1.94 Million | 47 Thousand |
| Net cash flow / Change in cash | 5.24 Billion | -1.36 Billion | 1.41 Billion | 40.87 Million | 20.44 Million | -42.15 Million |
| Free Cash Flow | 547.9 Million | -97.14 Million | 217.11 Million | 1.67 Billion | 710.6 Million | -478.32 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 369.2 Million | 538 Million | 1.97 Billion | 522.2 Million | 481 Million | 434.8 Million |
| Depreciation & Amortization | 127.3 Million | - | 361.8 Million | 92.9 Million | 82.5 Million | 70.4 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | 96.6 Million | - | - | - |
| Change in working capital | 173 Million | - | -861.6 Million | - | 399.8 Million | -629 Million |
| Other non-cash items | -369.2 Million | -538 Million | 1.25 Billion | -522.2 Million | 87.4 Million | 124.6 Million |
| Investing Cash Flow | 752 Million | - | -402.1 Million | - | -1.53 Billion | 2.48 Billion |
| Investments in PPE | -564 Million | - | -922.7 Million | - | -178.2 Million | -160 Million |
| Acquisitions | - | - | -1.66 Billion | - | - | - |
| Investment purchases | -667 Million | - | -2.25 Billion | - | -2.09 Billion | - |
| Sales/Maturities of investments | 1.41 Billion | - | 4.43 Billion | - | 729.4 Million | 2.64 Billion |
| Other Investing Activities | 3 Million | - | 2.75 Billion | - | - | - |
| Financing Cash Flow | - | - | -818.6 Million | - | -17.6 Million | -9 Million |
| Debt repayment | -3 Million | - | -14 Million | - | - | - |
| Dividends payments | - | - | -771.23 Million | - | - | - |
| Common Stock Repurchased | - | - | -21.9 Million | - | -21.9 Million | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -3 Million | - | -44.3 Million | - | 7 Million | -7 Million |
| Accounts receivables | - | - | 40.4 Million | - | - | - |
| Accounts payables | - | - | 50.2 Million | - | - | - |
| Inventory | - | - | -626.1 Million | - | - | - |
| Other working capital | 173 Million | - | -326.1 Million | - | - | - |
| Cash at beginning of period | 575.82 Million | - | 172.63 Million | 4.37 Billion | 5.17 Billion | 172.63 Million |
| Cash at end of period | 5.31 Billion | - | 5.42 Billion | 522.2 Million | 4.37 Billion | 5.17 Billion |
| Capital Expenditure | -564 Million | - | -922.7 Million | - | -178.2 Million | -160 Million |
| Effect of forex changes on cash | - | - | 3.7 Million | - | -130.8 Million | 2.67 Billion |
| Net cash flow / Change in cash | 4.73 Billion | - | 5.24 Billion | -3.85 Billion | -802.5 Million | 5 Billion |
| Free Cash Flow | - | - | 547.9 Million | 522.2 Million | 707.5 Million | -300 Million |
CVPBF
300685
XPPLF
002274
INVEO
BB